A role for metabolism in Rett syndrome pathogenesis

References

• Rett A. [Cerebral atrophic syndrome in hyperammonemia in children]. Landarzt 1968; 44:797 - 801; PMID: 5720544
   PubMedGoogle Scholar
• Campos-Castelló J, Peral Guerra M, Riviere Gómez A, Oliete García F, Herranz Tanarro J, Toledano Barrero M, Espinar Sierra J, Cristobal Sassot S, Lautre Ecenarro MJ, Franco Carcedo C, et al. [Rett’s syndrome: study of 15 cases]. An Esp Pediatr 1988; 28:286 - 92; PMID: 2456708
   PubMedGoogle Scholar
• Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 1999; 23:185 - 8; http://dx.doi.org/10.1038/13810; PMID: 10508514
   PubMed Web of Science ®Google Scholar
• Bienvenu T, Chelly J. Molecular genetics of Rett syndrome: when DNA methylation goes unrecognized. Nat Rev Genet 2006; 7:415 - 26; http://dx.doi.org/10.1038/nrg1878; PMID: 16708070
   PubMed Web of Science ®Google Scholar
• Guy J, Gan J, Selfridge J, Cobb S, Bird A. Reversal of neurological defects in a mouse model of Rett syndrome. Science 2007; 315:1143 - 7; http://dx.doi.org/10.1126/science.1138389; PMID: 17289941
   PubMed Web of Science ®Google Scholar
• Buchovecky CM, Turley SD, Brown HM, Kyle SM, McDonald JG, Liu B, Pieper AA, Huang W, Katz DM, Russell DW, et al. A suppressor screen in Mecp2 mutant mice implicates cholesterol metabolism in Rett syndrome. Nat Genet 2013; 45:1013 - 20; http://dx.doi.org/10.1038/ng.2714; PMID: 23892605
   PubMed Web of Science ®Google Scholar
• Pfrieger FW, Ungerer N. Cholesterol metabolism in neurons and astrocytes. Prog Lipid Res 2011; 50:357 - 71; http://dx.doi.org/10.1016/j.plipres.2011.06.002; PMID: 21741992
   PubMed Web of Science ®Google Scholar
• Kriaucionis S, Paterson A, Curtis J, Guy J, Macleod N, Bird A. Gene expression analysis exposes mitochondrial abnormalities in a mouse model of Rett syndrome. Mol Cell Biol 2006; 26:5033 - 42; http://dx.doi.org/10.1128/MCB.01665-05; PMID: 16782889
   PubMed Web of Science ®Google Scholar
• Rossignol DA, Frye RE. A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures. Mol Psychiatry 2012; 17:389 - 401; http://dx.doi.org/10.1038/mp.2011.165; PMID: 22143005
   PubMed Web of Science ®Google Scholar
• Waterham HR. Defects of cholesterol biosynthesis. FEBS Lett 2006; 580:5442 - 9; http://dx.doi.org/10.1016/j.febslet.2006.07.027; PMID: 16876788
   PubMed Web of Science ®Google Scholar
• Neul JL, Kaufmann WE, Glaze DG, Christodoulou J, Clarke AJ, Bahi-Buisson N, Leonard H, Bailey ME, Schanen NC, Zappella M, et al, RettSearch Consortium. Rett syndrome: revised diagnostic criteria and nomenclature. Ann Neurol 2010; 68:944 - 50; http://dx.doi.org/10.1002/ana.22124; PMID: 21154482
   PubMed Web of Science ®Google Scholar
• Percy AK. Rett syndrome: exploring the autism link. Arch Neurol 2011; 68:985 - 9; http://dx.doi.org/10.1001/archneurol.2011.149; PMID: 21825235
   PubMed Web of Science ®Google Scholar
• Osterweil EK, Chuang SC, Chubykin AA, Sidorov M, Bianchi R, Wong RK, Bear MF. Lovastatin corrects excess protein synthesis and prevents epileptogenesis in a mouse model of fragile X syndrome. Neuron 2013; 77:243 - 50; http://dx.doi.org/10.1016/j.neuron.2012.01.034; PMID: 23352161
   PubMed Web of Science ®Google Scholar
• Ardern-Holmes SL, North KN. Therapeutics for childhood neurofibromatosis type 1 and type 2. Curr Treat Options Neurol 2011; 13:529 - 43; http://dx.doi.org/10.1007/s11940-011-0142-9; PMID: 21850405
   PubMed Web of Science ®Google Scholar
• Sticozzi C, Belmonte G, Pecorelli A, Cervellati F, Leoncini S, Signorini C, Ciccoli L, De Felice C, Hayek J, Valacchi G. Scavenger receptor B1 post-translational modifications in Rett syndrome. FEBS Lett 2013; 587:2199 - 204; http://dx.doi.org/10.1016/j.febslet.2013.05.042; PMID: 23711372
   PubMed Web of Science ®Google Scholar
• Daniels SR, Greer FR, Committee on Nutrition. Lipid screening and cardiovascular health in childhood. Pediatrics 2008; 122:198 - 208; http://dx.doi.org/10.1542/peds.2008-1349; PMID: 18596007
   PubMed Web of Science ®Google Scholar
• Schreurs BG. The effects of cholesterol on learning and memory. Neurosci Biobehav Rev 2010; 34:1366 - 79; http://dx.doi.org/10.1016/j.neubiorev.2010.04.010; PMID: 20470821
   PubMed Web of Science ®Google Scholar
• Roy A, Pahan K. Prospects of statins in Parkinson disease. Neuroscientist 2011; 17:244 - 55; http://dx.doi.org/10.1177/1073858410385006; PMID: 21252380
   PubMed Web of Science ®Google Scholar
• Dalla Y, Singh N, Jaggi AS, Singh D. Memory restorative role of statins in experimental dementia: an evidence of their cholesterol dependent and independent actions. Pharmacol Rep 2010; 62:784 - 96; http://dx.doi.org/10.1016/S1734-1140(10)70339-X; PMID: 21098862
   PubMed Web of Science ®Google Scholar
• Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics 2011; 128:Suppl 5 S213 - 56; http://dx.doi.org/10.1542/peds.2009-2107C; PMID: 22084329
   PubMedGoogle Scholar
• Kwiterovich PO. Clinical and laboratory assessment of cardiovascular risk in children: Guidelines for screening, evaluation, and treatment. J Clin Lipidol 2008; 2:248 - 66; http://dx.doi.org/10.1016/j.jacl.2008.06.003; PMID: 21291741
   PubMed Web of Science ®Google Scholar
• Pitcher MR, Ward CS, Arvide EM, Chapleau CA, Pozzo-Miller L, Hoeflich A, Sivaramakrishnan M, Saenger S, Metzger F, Neul JL. Insulinotropic treatments exacerbate metabolic syndrome in mice lacking MeCP2 function. Hum Mol Genet 2013; 22:2626 - 33; http://dx.doi.org/10.1093/hmg/ddt111; PMID: 23462290
   PubMed Web of Science ®Google Scholar
• Penning C, van der Wouden JC. Increased plasma leptin levels and valproate use in patients with Rett syndrome. [author reply e.] J Pediatr 2007; 151:e15 - , author reply e15; http://dx.doi.org/10.1016/j.jpeds.2007.06.032; PMID: 17889056
   PubMedGoogle Scholar
• Rouach N, Koulakoff A, Abudara V, Willecke K, Giaume C. Astroglial metabolic networks sustain hippocampal synaptic transmission. Science 2008; 322:1551 - 5; http://dx.doi.org/10.1126/science.1164022; PMID: 19056987
   PubMed Web of Science ®Google Scholar
• Liebhaber GM, Riemann E, Baumeister FA. Ketogenic diet in Rett syndrome. J Child Neurol 2003; 18:74 - 5; http://dx.doi.org/10.1177/08830738030180011801; PMID: 12661945
   PubMed Web of Science ®Google Scholar
• Lyst MJ, Ekiert R, Ebert DH, Merusi C, Nowak J, Selfridge J, Guy J, Kastan NR, Robinson ND, de Lima Alves F, et al. Rett syndrome mutations abolish the interaction of MeCP2 with the NCoR/SMRT co-repressor. Nat Neurosci 2013; 16:898 - 902; http://dx.doi.org/10.1038/nn.3434; PMID: 23770565
   PubMed Web of Science ®Google Scholar
• Knutson SK, Chyla BJ, Amann JM, Bhaskara S, Huppert SS, Hiebert SW. Liver-specific deletion of histone deacetylase 3 disrupts metabolic transcriptional networks. EMBO J 2008; 27:1017 - 28; http://dx.doi.org/10.1038/emboj.2008.51; PMID: 18354499
   PubMed Web of Science ®Google Scholar
• Day CP, James OF. Steatohepatitis: a tale of two “hits”?. Gastroenterology 1998; 114:842 - 5; http://dx.doi.org/10.1016/S0016-5085(98)70599-2; PMID: 9547102
   PubMed Web of Science ®Google Scholar
• Pardal-Fernandez JM, Jerez-Garcia P, Onsurbe-Ramirez I, Marco-Giner J. Rett syndrome: a case presenting with atypical seizures. Neurophysiological and clinical aspects. Neurophysiologie clinique =. Clin Neurophysiol 2004; 34:49 - 57; http://dx.doi.org/10.1016/j.neucli.2003.08.003
   Web of Science ®Google Scholar
• Bryant AE 3rd, Dreifuss FE. Valproic acid hepatic fatalities. III. U.S. experience since 1986. Neurology 1996; 46:465 - 9; http://dx.doi.org/10.1212/WNL.46.2.465; PMID: 8614514
   PubMed Web of Science ®Google Scholar